BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) had its price objective hoisted by equities researchers at Wells Fargo & Company from $43.00 to $50.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Wells Fargo & Company‘s target price points to a potential upside of 23.00% from the stock’s current price.
Several other analysts have also issued reports on the company. TD Cowen reissued a “buy” rating on shares of BrightSpring Health Services in a report on Tuesday, January 27th. Zacks Research downgraded BrightSpring Health Services from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, January 6th. BTIG Research reissued a “buy” rating and issued a $55.00 target price on shares of BrightSpring Health Services in a report on Monday. KeyCorp upgraded shares of BrightSpring Health Services from a “sector weight” rating to an “overweight” rating and set a $45.00 target price on the stock in a research note on Friday, December 12th. Finally, Stephens initiated coverage on shares of BrightSpring Health Services in a research report on Wednesday, December 10th. They issued an “overweight” rating and a $44.00 price target for the company. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, BrightSpring Health Services presently has a consensus rating of “Moderate Buy” and a consensus price target of $42.85.
Check Out Our Latest Stock Analysis on BTSG
BrightSpring Health Services Stock Performance
BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) last issued its quarterly earnings data on Friday, February 27th. The company reported $0.33 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.01). The business had revenue of $3.55 billion for the quarter, compared to the consensus estimate of $3.38 billion. BrightSpring Health Services had a net margin of 1.48% and a return on equity of 12.66%. The company’s revenue was up 29.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.11 EPS. On average, equities research analysts predict that BrightSpring Health Services will post 0.59 EPS for the current year.
Institutional Trading of BrightSpring Health Services
A number of institutional investors and hedge funds have recently bought and sold shares of BTSG. Invesco Ltd. boosted its holdings in shares of BrightSpring Health Services by 47.7% during the 2nd quarter. Invesco Ltd. now owns 9,119,408 shares of the company’s stock valued at $215,127,000 after purchasing an additional 2,946,811 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of BrightSpring Health Services by 30.5% in the fourth quarter. Vanguard Group Inc. now owns 12,533,656 shares of the company’s stock worth $469,385,000 after buying an additional 2,928,953 shares in the last quarter. The Manufacturers Life Insurance Company boosted its stake in BrightSpring Health Services by 936.4% during the second quarter. The Manufacturers Life Insurance Company now owns 2,276,583 shares of the company’s stock valued at $53,705,000 after buying an additional 2,056,920 shares during the last quarter. State Street Corp grew its holdings in BrightSpring Health Services by 99.5% during the 4th quarter. State Street Corp now owns 4,033,149 shares of the company’s stock valued at $151,041,000 after buying an additional 2,011,095 shares in the last quarter. Finally, Jane Street Group LLC increased its stake in BrightSpring Health Services by 855.4% in the 2nd quarter. Jane Street Group LLC now owns 2,076,730 shares of the company’s stock worth $48,990,000 after acquiring an additional 1,859,369 shares during the last quarter.
Key BrightSpring Health Services News
Here are the key news stories impacting BrightSpring Health Services this week:
- Positive Sentiment: Mizuho raised its price target on BTSG from $45 to $50 and maintained an “outperform” rating, signaling stronger analyst confidence and a material upside to current levels. Article Title
- Positive Sentiment: Wells Fargo boosted its price target from $43 to $50 and assigned an “overweight” rating, reinforcing the bullish analyst view and likely supporting demand at current prices. Article Title
- Neutral Sentiment: A Zacks comparison piece examines BTSG versus peer Caris Life Sciences (CAI) for value-oriented investors; this is a general research/idea piece rather than a company-specific catalyst. BTSG vs. CAI: Which Stock Is the Better Value Option?
- Neutral Sentiment: Company press releases announce a concurrent share repurchase alongside the planned secondary sale; management intends buyback activity, but details/timing relative to the secondary sale are unclear. BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase
- Neutral Sentiment: Short-interest data reported for early March appears internally inconsistent (zeros and NaN values) and is likely a reporting error — it does not provide a meaningful signal to explain today’s move.
- Negative Sentiment: Selling stockholders priced a large secondary offering of 20,000,000 shares at $41.15 per share; BrightSpring is not selling any new shares and selling stockholders receive the proceeds. The size (20M shares) versus typical daily turnover can increase supply pressure and likely weighed on the stock today. BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
About BrightSpring Health Services
BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.
Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.
Read More
- Five stocks we like better than BrightSpring Health Services
- New Copper-Rich “Kraken” Zone Discovered
- 1,500 Banks Just Handed the Fed Your Bank Account
- Silver’s squeeze is tightening – opportunity forming
- America’s 1776 happening again
- Here are subject line variants for this gold/Iran escalation creative:
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.
